Day case unicompartmental knee replacement: An update of the Torbay experience.


Journal

The Knee
ISSN: 1873-5800
Titre abrégé: Knee
Pays: Netherlands
ID NLM: 9430798

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 08 01 2021
revised: 04 06 2021
accepted: 13 08 2021
pubmed: 10 9 2021
medline: 21 10 2021
entrez: 9 9 2021
Statut: ppublish

Résumé

Hospitals throughout the United Kingdom face significant challenges in regards to inpatient bed capacity, leading to growing interest in day case arthroplasty. Day case Unicompartmental Knee Replacement (UKR) has been offered within our unit since 2010, with successive evaluations of pathway outcomes performed in 2011 and 2015. Since then, our day case UKR pathway has expanded. This study aims to evaluate the safety, efficiency and patient satisfaction with this expanded pathway. Data was prospectively collected for all patients undergoing a UKR between January 2017 and August 2019. Data collected included the pathway planned, date of admission, date of discharge and re-admissions to hospital within 30 days of surgery. Patient satisfaction was evaluated via a follow-up questionnaire. 109 patients underwent a UKR between January 2017 and August 2019. 83 patients (76%) were planned through the day case pathway. 63 patients were successfully discharged on the day of surgery. One day case pathway and two inpatient pathway patients were re-admitted within 30 days of surgery with medical conditions. A high level of patient satisfaction with our day case pathway was identified. UKR with planned discharge on the day of surgery is possible for a large proportion of patients provided that robust pathway and protocol design is undertaken. Following 10 years' experience, our day case UKR pathway has increasingly become the default for the majority of our patients. We report high patient satisfaction and low 30-day re-admission rates. However, 100% success rate for day of surgery discharge remains challenging.

Sections du résumé

BACKGROUND BACKGROUND
Hospitals throughout the United Kingdom face significant challenges in regards to inpatient bed capacity, leading to growing interest in day case arthroplasty. Day case Unicompartmental Knee Replacement (UKR) has been offered within our unit since 2010, with successive evaluations of pathway outcomes performed in 2011 and 2015. Since then, our day case UKR pathway has expanded. This study aims to evaluate the safety, efficiency and patient satisfaction with this expanded pathway.
METHODS METHODS
Data was prospectively collected for all patients undergoing a UKR between January 2017 and August 2019. Data collected included the pathway planned, date of admission, date of discharge and re-admissions to hospital within 30 days of surgery. Patient satisfaction was evaluated via a follow-up questionnaire.
RESULTS RESULTS
109 patients underwent a UKR between January 2017 and August 2019. 83 patients (76%) were planned through the day case pathway. 63 patients were successfully discharged on the day of surgery. One day case pathway and two inpatient pathway patients were re-admitted within 30 days of surgery with medical conditions. A high level of patient satisfaction with our day case pathway was identified.
CONCLUSION CONCLUSIONS
UKR with planned discharge on the day of surgery is possible for a large proportion of patients provided that robust pathway and protocol design is undertaken. Following 10 years' experience, our day case UKR pathway has increasingly become the default for the majority of our patients. We report high patient satisfaction and low 30-day re-admission rates. However, 100% success rate for day of surgery discharge remains challenging.

Identifiants

pubmed: 34500429
pii: S0968-0160(21)00201-5
doi: 10.1016/j.knee.2021.08.017
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

166-172

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Alasdair Barrie (A)

Torbay and South Devon NHS Foundation Trust, Torbay Hospital, Lowes Bridge, Torquay TQ2 7AA, United Kingdom. Electronic address: alasdair.barrie@nhs.net.

Michael Hockings (M)

Torbay and South Devon NHS Foundation Trust, Torbay Hospital, Lowes Bridge, Torquay TQ2 7AA, United Kingdom. Electronic address: Michael.hockings@nhs.net.

David Isaac (D)

Torbay and South Devon NHS Foundation Trust, Torbay Hospital, Lowes Bridge, Torquay TQ2 7AA, United Kingdom. Electronic address: davidisaac@nhs.net.

Claire Blandford (C)

Torbay and South Devon NHS Foundation Trust, Torbay Hospital, Lowes Bridge, Torquay TQ2 7AA, United Kingdom. Electronic address: claireblandford@nhs.net.

Mary Stocker (M)

Torbay and South Devon NHS Foundation Trust, Torbay Hospital, Lowes Bridge, Torquay TQ2 7AA, United Kingdom. Electronic address: mary.stocker@nhs.net.

Michael Kent (M)

Torbay and South Devon NHS Foundation Trust, Torbay Hospital, Lowes Bridge, Torquay TQ2 7AA, United Kingdom. Electronic address: michael.kent1@nhs.net.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH